Safety and Effectiveness of Orbera365™ Intragastric Balloon System
NCT: NCT07062094 · RECRUITING
Brief Summary
This is a prospective, multi-center, standard of care registry offered to subjects in the EU only that have already agreed to receive the Orbera365™ Intragastric Balloon (IGB) System for weight loss. Subjects that agree to participate in the registry will have data reported associated with standard of care weight management visits during the time the device is implanted (in-dwell period), with an additional visit 30 days after the removal procedure.
Frequently Asked Questions
What is Safety and Effectiveness of Orbera365™ Intragastric Balloon System?
Safety and Effectiveness of Orbera365™ Intragastric Balloon System is a clinical trial registered under NCT07062094. Current status: RECRUITING.
What is the status of NCT07062094?
The current status of NCT07062094 (Safety and Effectiveness of Orbera365™ Intragastric Balloon System) is: RECRUITING.
When did Safety and Effectiveness of Orbera365™ Intragastric Balloon System start?
Safety and Effectiveness of Orbera365™ Intragastric Balloon System started on 2026-04-07.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.